Main > RHEUMATOLOGY > USA. P. AS>Treat.>JAK Inhibitor Tab

---

USA. P. AS>Treat.>JAK Inhibitor Tab's subsections
(*) EU CE Mark Date: 2021. 11.18.
(*) USA Approval Date: 2021. 12
Company
Generic Name: TOFACITINIB
JAK: JAnus Kinase
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2022. 06.28
RTM
RTM Web-Site

USA. P. AS>Treat.>JAK Inhibitor Tab's products
This section has no products